109 related articles for article (PubMed ID: 9641623)
1. Anticoagulant activity of dextran derivatives.
de Raucourt E; Mauray S; Chaubet F; Maiga-Revel O; Jozefowicz M; Fischer AM
J Biomed Mater Res; 1998 Jul; 41(1):49-57. PubMed ID: 9641623
[TBL] [Abstract][Full Text] [Related]
2. Comparative anticoagulant activity and influence on thrombin generation of dextran derivatives and of a fucoidan fraction.
Mauray S; De Raucourt E; Chaubet F; Maïga-Revel O; Sternberg C; Fischer AM
J Biomater Sci Polym Ed; 1998; 9(4):373-87. PubMed ID: 9586785
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of thrombin inhibition by heparin cofactor II in the presence of dermatan sulphates, native or oversulphated, and a heparin-like dextran derivative.
Maaroufi RM; Jozefowicz M; Tapon-Bretaudière J; Jozefonvicz J; Fischer AM
Biomaterials; 1997 Feb; 18(4):359-66. PubMed ID: 9068899
[TBL] [Abstract][Full Text] [Related]
4. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant activity of dextran derivatives. Part II: Mechanism of thrombin inactivation.
Fischer AM; Mauzac M; Tapon-Bretaudiere J; Jozefonvicz J
Biomaterials; 1985 May; 6(3):198-202. PubMed ID: 2408688
[TBL] [Abstract][Full Text] [Related]
6. Carboxymethyl benzylamide sulfonate dextrans (CMDBS), a family of biospecific polymers endowed with numerous biological properties: a review.
Logeart-Avramoglou D; Jozefonvicz J
J Biomed Mater Res; 1999; 48(4):578-90. PubMed ID: 10421704
[TBL] [Abstract][Full Text] [Related]
7. Modulating the degree of fucosylation of fucosylated chondroitin sulfate enhances heparin cofactor II-dependent thrombin inhibition.
Xu L; Gao N; Xiao C; Lin L; Purcell SW; Wu M; Zhao J
Eur J Med Chem; 2018 Jun; 154():133-143. PubMed ID: 29787913
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
Buchanan MR; Brister SJ
Thromb Res; 2000 Sep; 99(6):603-12. PubMed ID: 10974347
[TBL] [Abstract][Full Text] [Related]
9. Highly sulfated dermatan sulfate from the skin of the ray Raja montagui: anticoagulant activity and mechanism of action.
Ben Mansour M; Dhahri M; Hassine M; Ajzenberg N; Venisse L; Ollivier V; Chaubet F; Jandrot-Perrus M; Maaroufi RM
Comp Biochem Physiol B Biochem Mol Biol; 2010 Jul; 156(3):206-15. PubMed ID: 20363356
[TBL] [Abstract][Full Text] [Related]
10. Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans.
Cosmi B; Cini M; Legnani C; Pancani C; Calanni F; Coccheri S
Thromb Res; 2003 Mar; 109(5-6):333-9. PubMed ID: 12818259
[TBL] [Abstract][Full Text] [Related]
11. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
[TBL] [Abstract][Full Text] [Related]
12. Thrombin inhibition by HCII in the presence of elastase-cleaved HCII and thrombin-HCII complex.
Maekawa H; Sato H; Tollefsen DM
Thromb Res; 2000 Dec; 100(5):443-51. PubMed ID: 11150588
[TBL] [Abstract][Full Text] [Related]
13. Thrombin inhibitory activity of heparin cofactor II depends on the molecular weight and sulfate amount of dextran sulfate.
Yamagishi R; Niwa M; Sakuragawa N
Thromb Res; 1986 Nov; 44(3):347-54. PubMed ID: 2432675
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate.
Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM
Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant hydrogels derived from crosslinked dextran. Part II: Mechanism of thrombin inactivation.
Aubert N; Mauzac M; Gulino D; Jozefonvicz J
Biomaterials; 1987 Mar; 8(2):100-4. PubMed ID: 2437972
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant and antiprotease activities of a heparinoid sulfated glucoside-bearing polymer.
Onishi M; Miyashita Y; Motomura T; Yamashita S; Sakamoto N; Akashi M
J Biomater Sci Polym Ed; 1998; 9(9):973-84. PubMed ID: 9747989
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of thrombin by sulfated polysaccharides isolated from green algae.
Hayakawa Y; Hayashi T; Lee J; Srisomporn P; Maeda M; Ozawa T; Sakuragawa N
Biochim Biophys Acta; 2000 Nov; 1543(1):86-94. PubMed ID: 11087944
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
[TBL] [Abstract][Full Text] [Related]
19. Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor II.
Shirk RA; Church FC; Wagner WD
Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1138-46. PubMed ID: 8792767
[TBL] [Abstract][Full Text] [Related]
20. Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin.
Holland CA; Henry AT; Whinna HC; Church FC
FEBS Lett; 2000 Nov; 484(2):87-91. PubMed ID: 11068038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
